×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| BAL PHARMA LTD. | 737.05 | 11.56 | 728.85 | 0.73 | 155.0 | 21.4 |
| TYCHE INDUSTRIES LTD. | 197.93 | 47.43 | 177.51 | 4.63 | 150 | 11.1 |
| AURO LABORATORIES LTD. | 31.96 | 0.51 | 30.55 | 0.08 | 145 | 41.6 |
Bal Pharma Ltd., with Security Code 524824, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 75.0 | 76.5 | 81.9 | 70.1 | 92.3 | 81.4 | 94.5 | 73.1 | 74.7 | 72.8 |
| Expenses | 69.0 | 70.3 | 73.7 | 63.3 | 84.6 | 73.9 | 84.3 | 66.1 | 67.2 | 65.2 |
| Operating Profit | 6.0 | 6.3 | 8.3 | 6.8 | 7.7 | 7.6 | 10.3 | 7.1 | 7.5 | 7.7 |
| OPM % | 8.01% | 8.23% | 10.09% | 9.75% | 8.29% | 9.36% | 10.91% | 9.67% | 10.01% | 10.6% |
| Other Income | 0.4 | 0.8 | 0.4 | 0.4 | 0.4 | 0.3 | 2.2 | 0.8 | 0.4 | 0.8 |
| Interest | 2.8 | 3.1 | 3.8 | 3.6 | 3.8 | 3.7 | 4.1 | 3.7 | 4.2 | 5.0 |
| Depreciation | 2.0 | 2.0 | 1.7 | 2.1 | 2.0 | 2.6 | 1.8 | 2.1 | 2.1 | 2.3 |
| Profit before tax | 1.6 | 1.9 | 3.2 | 1.5 | 2.2 | 1.7 | 6.7 | 2.1 | 1.5 | 1.2 |
| Tax % | 29.5% | 24% | 33.9% | 21.9% | 28.2% | 24.9% | 6.8% | 17% | 20.8% | 4% |
| Net Profit | 1.1 | 1.5 | 2.1 | 1.2 | 1.6 | 1.3 | 6.2 | 1.7 | 1.2 | 1.2 |
| EPS in Rs | 0.73 | 0.95 | 1.36 | 0.76 | 1.02 | 0.8 | 4.18 | 1.11 | 0.76 | 0.73 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 69.8 | 75.3 | 76.6 | 82.5 | 70.4 | 92.5 | 81.7 | 94.6 | 74.4 | 73.7 |
| Expenses | 64.8 | 69.5 | 70.5 | 74.3 | 63.9 | 84.9 | 73.9 | 85.0 | 67.9 | 66.0 |
| Operating Profit | 5.0 | 5.8 | 6.1 | 8.2 | 6.4 | 7.7 | 7.8 | 9.6 | 6.5 | 7.7 |
| OPM % | 7.2% | 7.7% | 8% | 9.9% | 9.2% | 8.3% | 9.5% | 10.1% | 8.7% | 10.4% |
| Other Income | 0.2 | 0.0 | 0.5 | 0.2 | 0.2 | 0.1 | 0.1 | 2.5 | 0.8 | -0.2 |
| Interest | 2.4 | 2.9 | 3.1 | 3.9 | 3.6 | 3.8 | 3.7 | 4.1 | 4.2 | 3.7 |
| Depreciation | 2.2 | 2.4 | 2.4 | 2.1 | 2.5 | 2.4 | 3.0 | 2.2 | 2.4 | 2.5 |
| Profit before tax | 0.7 | 0.6 | 1.1 | 2.4 | 0.4 | 1.6 | 1.3 | 5.8 | 0.6 | 1.4 |
| Tax % | 58.3% | 79% | 43.9% | 32.9% | 78% | 39.4% | 32.9% | 3.8% | 57.9% | 23.5% |
| Net Profit | 0.3 | 0.1 | 0.6 | 1.6 | 0.1 | 1.0 | 0.8 | 5.5 | 0.3 | 1.0 |
| EPS in Rs | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 11% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 67% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 21% |
| 3 Years: | -1% |
| 1 Year: | -17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 11% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 28% |
| 3 Years: | 16% |
| TTM: | 108% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 21% |
| 3 Years: | -1% |
| 1 Year: | -17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|